Phibro Animal Health Corporation - (PAHC) Company Bio
Phibro Animal Health Corporation is a diversified global developer, manufacturer and marketer of a broad range of animal health and mineral nutrition products for use in the production of poultry, swine, cattle, dairy and aquaculture. The company was founded in 2000 and is based in Teaneck, New Jersey.
PAHC Price Forecast Based on DCF Valuation
DCF Fair Value Target:
We started the process of determining a valid price forecast for Phibro Animal Health Corp with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Phibro Animal Health Corp ranked in the 46th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 18.33%. In terms of the factors that were most noteworthy in this DCF analysis for PAHC, they are:
The company's balance sheet shows it gets 68% of its capital from equity, and 32% of its capital from debt. Notably, its equity weight is greater than only 18.59% of US equities in the Healthcare sector yielding a positive free cash flow.
Phibro Animal Health Corp's weighted average cost of capital (WACC) is 8%; for context, that number is higher than merely 7.31% of tickers in our DCF set.
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
Want more companies with a valuation profile/forecast similar to that of Phibro Animal Health Corp? See INBP, IQV, LMAT, BDX, and LCI.
Phibro Animal Health Corporation (NASDAQ:PAHC) expects to announce its second quarter financial results on Wednesday, February 3, 2021, after the market closes. Phibro management will host a conference call and webcast on Thursday, February 4, 2021 at 9:00 AM Eastern Time.